KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cigna (CI) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Cigna (CI) over the last 9 years, with Q3 2025 value amounting to $6.0 billion.

  • Cigna's Cash & Equivalents rose 232.68% to $6.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 232.68%. This contributed to the annual value of $7.6 billion for FY2024, which is 347.74% down from last year.
  • Latest data reveals that Cigna reported Cash & Equivalents of $6.0 billion as of Q3 2025, which was up 232.68% from $4.3 billion recorded in Q2 2025.
  • In the past 5 years, Cigna's Cash & Equivalents ranged from a high of $9.6 billion in Q2 2023 and a low of $3.5 billion during Q3 2021
  • For the 5-year period, Cigna's Cash & Equivalents averaged around $6.4 billion, with its median value being $6.5 billion (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 5009.82% in 2021, then surged by 11680.62% in 2023.
  • Cigna's Cash & Equivalents (Quarter) stood at $5.1 billion in 2021, then rose by 16.59% to $5.9 billion in 2022, then surged by 32.04% to $7.8 billion in 2023, then fell by 3.48% to $7.6 billion in 2024, then dropped by 20.2% to $6.0 billion in 2025.
  • Its last three reported values are $6.0 billion in Q3 2025, $4.3 billion for Q2 2025, and $8.3 billion during Q1 2025.